Vanda Pharmaceuticals | Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Acadia Pharmaceuticals USD 847.02M 85.02M 2025-09
Agios Pharmaceuticals USD 92.71M 11.84M 2025-09
Akebia Therapeutics USD 166.44M 29.14M 2025-09
Alnylam Pharmaceuticals USD 1.49B 376.56M 2025-09
Anika Therapeutics USD 57.99M 4.82M 2025-09
Arrowhead Research USD 201.64M 112.94M 2025-12
AstraZeneca USD 8.14B 1.08B 2025-09
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Eli Lilly USD 9.79B 6.42B 2025-09
Enanta Pharmaceuticals USD 32.3M 12.51M 2025-09
Esperion Therapeutics USD 92.45M 6.39M 2025-09
Halozyme Therapeutics USD 419.66M 357.8M 2025-09
Heron Therapeutics USD 43.07M 26.55M 2025-09
Insmed USD 334.76M 949.56M 2025-09
J&J USD 18.23B 10.35B 2025-09
Lexicon Pharmaceuticals USD 21.36M 41.52M 2025-06
Ligand Pharmaceuticals USD 664.52M 596.85M 2025-09
Merck USD 18.17B 10.16B 2025-09
Minerva Neurosciences USD 12.29M 2.96M 2025-09
Moderna USD 1.13B 147M 2025-09
Novartis USD 9.56B 2.9B 2025-09
Pfizer USD 1.34B 295M 2025-09
PTC Therapeutics USD 672.62M 344.77M 2025-09
Puma Biotechnology USD 53.52M 1.14M 2025-09
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Takeda JPY 654.94B 26.55B 2025-12
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
Vanda Pharmaceuticals USD 70.02M 10.96M 2025-09
Veracyte USD 315.57M 96.07M 2025-09


Vanda Pharmaceuticals Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.